Further examination regarding the correlation between the serum or intratumoral RLN2 concentration and the immunohistochemical status of RLN2 is necessary to use RLA2 evaluation for clinical predictions or as a prognostic marker for endometrial cancer. The gene discussed is RLN2; the disease is endometrial cancer.